hVIVO PLC
LSE:HVO
hVIVO PLC
LSE:HVO
Price:
6.59
GBX
-1.64%
Market Closed
Market Cap:
£45.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
hVIVO PLC
LSE:HVO
|
UK |
|
A
|
Atlantia SpA
F:AU9
|
IT |
Multiples-Based Value
The Multiples-Based Value of one
HVO
stock under the Base Case scenario is
14.79
GBX.
Compared to the current market price of 6.59 GBX,
hVIVO PLC
is
Undervalued by 55%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HVO
Multiples-Based Value
Base Case
14.79
GBX
Undervaluation 55%
Multiples Across Competitors
HVO Competitors Multiples
hVIVO PLC Competitors
hVIVO PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
hVIVO PLC
LSE:HVO
|
46m GBP | 0.9 | 8.7 | 3.2 | 4.9 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
967B USD | 338.6 | 4 009 | 1 148.8 | 2 212.1 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
184.6B USD | 4.1 | 27.5 | 19.1 | 25.7 | |
| US |
|
Danaher Corp
NYSE:DHR
|
132.3B USD | 5.4 | 36.8 | 18.7 | 27.3 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33.3B CHF | 5.2 | 36 | 26.8 | 26.8 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
268.9B CNY | 6.1 | 17.9 | 18 | 18 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.9B USD | 4.5 | 24.9 | 18.3 | 21.6 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.7B USD | 9.4 | 46.5 | 30 | 37.8 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.1B USD | 1.8 | 21.1 | 11.8 | 17.7 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.8B USD | 6.4 | 29.5 | 21.9 | 24.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
